Chromosomal Abnormalities Subdivide Ependymal Tumors into Clinically Relevant Groups
Authors:
- Kenneth AldapeKAKenneth Aldape
- Andrew BollenABAndrew Bollen
- C. David JamesCJC. David James
- Kathleen LambornKLKathleen Lamborn
- Mitchel BergerMBMitchel Berger
- Burt G. FeuersteinBFBurt G. Feuerstein
- 1 March 2001
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 158 (3) , 1137-1143
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- A Multi-Institutional Retrospective Study of Intracranial Ependymoma in ChildrenJournal of Pediatric Hematology/Oncology, 1999
- Genetic analysis of glioblastoma multiforme provides evidence for subgroups within the gradeGenes, Chromosomes and Cancer, 1998
- Ependymoma: Results, Prognostic Factors and Treatment RecommendationsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- Exon scanning for mutations of the nf2 gene in pediatric ependymomas, rhabdoid tumors and meningiomasInternational Journal of Cancer, 1995
- Molecular analysis of genetic changes in ependymomasGenes, Chromosomes and Cancer, 1995
- Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridizationInternational Journal of Cancer, 1995
- Computer image analysis of comparative genomic hybridizationCytometry, 1995
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- Lack of histopathological correlation of malignant ependymomas with postoperative survivalJournal of Neurosurgery, 1989
- Neurofibromatosis 2New England Journal of Medicine, 1988